GRK5
Basic information
Region (hg38): 10:119207571-119459745
Previous symbols: [ "GPRK5" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GRK5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 32 | 37 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 3 | |||||
Total | 0 | 0 | 32 | 4 | 7 |
Variants in GRK5
This is a list of pathogenic ClinVar variants found in the GRK5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-119207947-GG-CT | Neurodevelopmental disorder | Uncertain significance (Jan 01, 2019) | ||
10-119250744-A-G | Benign (Feb 24, 2021) | |||
10-119326564-T-G | not specified | Uncertain significance (Feb 05, 2024) | ||
10-119326578-A-G | not specified | Uncertain significance (Apr 25, 2023) | ||
10-119326594-A-G | not specified | Uncertain significance (Mar 07, 2024) | ||
10-119326608-A-T | not specified | Uncertain significance (Dec 05, 2022) | ||
10-119380821-A-T | not specified | Uncertain significance (Jun 29, 2023) | ||
10-119380822-T-G | not specified | Uncertain significance (Dec 07, 2021) | ||
10-119396752-A-G | not specified | Uncertain significance (Apr 22, 2024) | ||
10-119396761-C-T | not specified | Uncertain significance (Oct 02, 2023) | ||
10-119423182-C-T | Benign (Jun 29, 2018) | |||
10-119423247-C-A | Benign (Jul 23, 2018) | |||
10-119423275-C-T | Benign (Jun 29, 2018) | |||
10-119423276-G-A | Likely benign (Apr 03, 2018) | |||
10-119425003-G-A | not specified | Uncertain significance (Mar 20, 2023) | ||
10-119425003-G-C | not specified | Uncertain significance (Jun 24, 2022) | ||
10-119430387-C-G | GRK5-related disorder | Likely benign (Oct 07, 2021) | ||
10-119430399-C-A | not specified | Uncertain significance (Jun 10, 2022) | ||
10-119431391-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
10-119431435-C-T | not specified | Uncertain significance (Jun 18, 2021) | ||
10-119436767-G-C | GRK5-related disorder | Uncertain significance (Jun 08, 2024) | ||
10-119436768-G-A | not specified | Uncertain significance (Aug 28, 2023) | ||
10-119436792-G-C | not specified | Uncertain significance (Nov 17, 2023) | ||
10-119436834-G-A | not specified | Uncertain significance (Dec 18, 2023) | ||
10-119442047-G-A | not specified | Uncertain significance (Sep 29, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GRK5 | protein_coding | protein_coding | ENST00000392870 | 16 | 248031 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.676 | 0.324 | 125729 | 0 | 19 | 125748 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.16 | 245 | 360 | 0.680 | 0.0000218 | 3904 |
Missense in Polyphen | 99 | 161.89 | 0.61154 | 1686 | ||
Synonymous | 0.377 | 144 | 150 | 0.961 | 0.0000101 | 1075 |
Loss of Function | 4.33 | 7 | 34.4 | 0.204 | 0.00000171 | 405 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000260 | 0.000260 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000475 | 0.0000462 |
European (Non-Finnish) | 0.0000799 | 0.0000791 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Serine/threonine kinase that phosphorylates preferentially the activated forms of a variety of G-protein- coupled receptors (GPCRs). Such receptor phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events leading to their down-regulation. Phosphorylates a variety of GPCRs, including adrenergic receptors, muscarinic acetylcholine receptors (more specifically Gi-coupled M2/M4 subtypes), dopamine receptors and opioid receptors. In addition to GPCRs, also phosphorylates various substrates: Hsc70- interacting protein/ST13, TP53/p53, HDAC5, and arrestin-1/ARRB1. Phosphorylation of ARRB1 by GRK5 inhibits G-protein independent MAPK1/MAPK3 signaling downstream of 5HT4-receptors. Phosphorylation of HDAC5, a repressor of myocyte enhancer factor 2 (MEF2) leading to nuclear export of HDAC5 and allowing MEF2- mediated transcription. Phosphorylation of TP53/p53, a crucial tumor suppressor, inhibits TP53/p53-mediated apoptosis. Phosphorylation of ST13 regulates internalization of the chemokine receptor. Phosphorylates rhodopsin (RHO) (in vitro) and a non G- protein-coupled receptor, LRP6 during Wnt signaling (in vitro). {ECO:0000269|PubMed:19661922, ECO:0000269|PubMed:19801552, ECO:0000269|PubMed:20038610, ECO:0000269|PubMed:20124405, ECO:0000269|PubMed:21728385}.;
- Pathway
- Endocytosis - Homo sapiens (human);Chemokine signaling pathway - Homo sapiens (human);Morphine addiction - Homo sapiens (human);Myometrial Relaxation and Contraction Pathways;Chemokine signaling pathway;Calcium Regulation in the Cardiac Cell;Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;IL-7 signaling;JAK STAT pathway and regulation;EPO signaling;VEGF;G alpha (q) signalling events;GPCR downstream signalling;Alpha-synuclein signaling
(Consensus)
Recessive Scores
- pRec
- 0.172
Intolerance Scores
- loftool
- 0.241
- rvis_EVS
- 0.05
- rvis_percentile_EVS
- 57.48
Haploinsufficiency Scores
- pHI
- 0.309
- hipred
- Y
- hipred_score
- 0.765
- ghis
- 0.541
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.985
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Grk5
- Phenotype
- endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype;
Zebrafish Information Network
- Gene name
- grk5l
- Affected structure
- post-vent region
- Phenotype tag
- abnormal
- Phenotype quality
- curled
Gene ontology
- Biological process
- apoptotic process;G protein-coupled receptor signaling pathway;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;tachykinin receptor signaling pathway;regulation of G protein-coupled receptor signaling pathway;positive regulation of cell population proliferation;Wnt signaling pathway;negative regulation of apoptotic process;fat cell differentiation;protein autophosphorylation;regulation of cell cycle
- Cellular component
- cytoplasm;cytosol;plasma membrane;nuclear speck;nuclear membrane
- Molecular function
- protein serine/threonine kinase activity;G protein-coupled receptor kinase activity;protein kinase C binding;protein binding;ATP binding;phospholipid binding;beta-adrenergic receptor kinase activity